Sorry, you need to enable JavaScript to visit this website.

VFEND® (voriconazole) Patient Counseling Information

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information).

Embryo-Fetal Toxicity

  • Advise female patients of the potential risks to a fetus.
  • Advise females of reproductive potential to use effective contraception during treatment with VFEND.

This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for VFEND®